These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 91166)

  • 41. Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia.
    Manki A; Ono T; Uenaka A; Seino Y; Nakayama E
    Cancer Res; 1998 May; 58(9):1960-4. PubMed ID: 9581839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW; Demsey A
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to Leukemia-associated antigens.
    Ting CC; Law LW
    J Immunol; 1977 Apr; 118(4):1259-64. PubMed ID: 191534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of specificity for viral and H-2 antigens by anomalous T killer cells generated in murine leukocyte cultures.
    Shain B; Holt CA; Lilly F
    J Immunol; 1982 Aug; 129(2):722-9. PubMed ID: 6177779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-Friend virus antibody-induced resistance of Friend virus-infected spleen cells to lysis mediated by anti-H-2 antisera.
    Bubbers JE; Lilly F
    Cancer Res; 1978 Sep; 38(9):2722-8. PubMed ID: 679177
    [No Abstract]   [Full Text] [Related]  

  • 48. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
    Welsh RM; Haspel MV; Parker DC; Holmes KV
    J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody blockade of lysis by T lymphocyte effectors generated against syngeneic SV40 transformed cells.
    Gooding LR
    J Immunol; 1979 Jun; 122(6):2328-36. PubMed ID: 221583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of tumorigenicity following in vitro MuLV infection is associated with induction of peritoneal natural killer cell activity.
    Thiel K; Genovesi EV; Iglehart JD; Bolognesi DP; Weinhold KJ
    Adv Exp Med Biol; 1988; 239():169-83. PubMed ID: 2849290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Occurrence of tumor antigen pRL1a specific CD8 T cells in spleen cells from syngeneic BALB/c, semiallogeneic (BALB/c x C57BL/6)F1 and allogeneic C57BL/6 mice.
    Hata H; Uenaka A; Takada I; Kenjo A; Takahashi M; Ono T; Fujita T; Nakayama E
    Int J Oncol; 2002 May; 20(5):1019-25. PubMed ID: 11956599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recognition of an Igh-linked histocompatibility antigen, H-40, on B-cell tumors by cytotoxic T lymphocytes.
    Forman J; Ciavarra R; Henderson LA
    Surv Immunol Res; 1985; 4(1):41-7. PubMed ID: 3923586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maturation of cytolytic T lymphocytes.
    Moscovitch M; Grossman Z; Rosen D; Berke G
    Cell Immunol; 1986 Oct; 102(1):52-67. PubMed ID: 3492278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship of membrane antigens on 141 (NZB) and EL4 (C57BL) lymphoma cells as demonstrated by antibody-induced resistance to complement-mediated cytotoxicity.
    Ran M; Yaakubowicz M; Talal N; Witz IP
    Eur J Immunol; 1978 Jun; 8(6):423-8. PubMed ID: 78855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigenic modulation in vitro. III. Failure to modulate H-2 antigens on several mouse tumors.
    Richards JM; Jacobson JB; Stackpole CW
    J Natl Cancer Inst; 1979 Apr; 62(4):825-32. PubMed ID: 311870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM; Lopez PF; Parks WP; Paul RD
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody-dependent cellular cytotoxicity against murine leukemia viral antigens: studies with human lymphoblastoid cell lines and human peripheral lymphocytes as effector cells comparing rabbit, goat, and mouse antisera.
    Peters CJ; Theofilopoulos AN
    J Immunol; 1977 Sep; 119(3):1089-96. PubMed ID: 70469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
    Reif AE
    Cancer Res; 1985 Jan; 45(1):25-31. PubMed ID: 3965136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
    Weiss A; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ; Howe ML
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.